Next generation proteomics with drug sensitivity screening identifies sub-clones informing therapeutic and drug development strategies for multiple myeloma patients

Ciara Tierney; Despina Bazou; Muntasir M. Majumder; Pekka Anttila; Raija Silvennoinen; Caroline A. Heckman; Paul Dowling; Peter O'Gorman

doi:10.1038/s41598-021-90149-y

Next generation proteomics with drug sensitivity screening identifies sub-clones informing therapeutic and drug development strategies for multiple myeloma patients

Ciara Tierney, Despina Bazou, Muntasir M. Majumder, Pekka Anttila, Raija Silvennoinen, Caroline A. Heckman, Paul Dowling, Peter O'Gorman

Tutkimustuotos: Artikkelijulkaisu › Artikkeli › Tieteellinen › vertaisarvioitu

Alkuperäiskieli	englanti
Artikkeli	12866
Lehti	Scientific Reports
Vuosikerta	11
Sivumäärä	15
ISSN	2045-2322
DOI - pysyväislinkit	https://doi.org/10.1038/s41598-021-90149-y
Tila	Julkaistu - 18 kesäk. 2021
OKM-julkaisutyyppi	A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä, vertaisarvioitu

Tieteenalat

3122 Syöpätaudit

Pääsy asiakirjaan

10.1038/s41598-021-90149-yLisenssi: CC BY

proteomicsLopullinen julkaistu versio, 6,12 MBLisenssi: CC BY

Siteeraa tätä

Tierney, C., Bazou, D., Majumder, M. M., Anttila, P., Silvennoinen, R., Heckman, C. A., Dowling, P., & O'Gorman, P. (2021). Next generation proteomics with drug sensitivity screening identifies sub-clones informing therapeutic and drug development strategies for multiple myeloma patients. Scientific Reports, 11, Artikkeli 12866. https://doi.org/10.1038/s41598-021-90149-y

@article{70866d6e1b444520b74ec94f0e873691,

title = "Next generation proteomics with drug sensitivity screening identifies sub-clones informing therapeutic and drug development strategies for multiple myeloma patients",

keywords = "IN-VIVO, ACTIVATION, INHIBITORS, POTENT, EXPRESSION, RESISTANCE, ADHESION, PROTEASOME, PATHWAY, BREAST, 3122 Cancers",

author = "Ciara Tierney and Despina Bazou and Majumder, {Muntasir M.} and Pekka Anttila and Raija Silvennoinen and Heckman, {Caroline A.} and Paul Dowling and Peter O'Gorman",

year = "2021",

month = jun,

day = "18",

doi = "10.1038/s41598-021-90149-y",

language = "English",

volume = "11",

journal = "Scientific Reports",

issn = "2045-2322",

publisher = "Nature Publishing Group",

}

Next generation proteomics with drug sensitivity screening identifies sub-clones informing therapeutic and drug development strategies for multiple myeloma patients. / Tierney, Ciara; Bazou, Despina; Majumder, Muntasir M. et al.
julkaisussa: Scientific Reports, Vuosikerta 11, 12866, 18.06.2021.

Tutkimustuotos: Artikkelijulkaisu › Artikkeli › Tieteellinen › vertaisarvioitu

TY - JOUR

T1 - Next generation proteomics with drug sensitivity screening identifies sub-clones informing therapeutic and drug development strategies for multiple myeloma patients

AU - Tierney, Ciara

AU - Bazou, Despina

AU - Majumder, Muntasir M.

AU - Anttila, Pekka

AU - Silvennoinen, Raija

AU - Heckman, Caroline A.

AU - Dowling, Paul

AU - O'Gorman, Peter

PY - 2021/6/18

Y1 - 2021/6/18

KW - IN-VIVO

KW - ACTIVATION

KW - INHIBITORS

KW - POTENT

KW - EXPRESSION

KW - RESISTANCE

KW - ADHESION

KW - PROTEASOME

KW - PATHWAY

KW - BREAST

KW - 3122 Cancers

U2 - 10.1038/s41598-021-90149-y

DO - 10.1038/s41598-021-90149-y

M3 - Article

SN - 2045-2322

VL - 11

JO - Scientific Reports

JF - Scientific Reports

M1 - 12866

ER -